Adam MacLean: A Closer Look at Immune Cell Interactions in Breast Cancer Metastasis
Adam MacLean/LinkedIn

Adam MacLean: A Closer Look at Immune Cell Interactions in Breast Cancer Metastasis

Adam MacLean, Associate Professor of Quantitative and Computational Biology at the University of Southern California, shared on LinkedIn:

“We made the cover.

This image shows immune cell subtypes interacting with cancer cells in breast cancer metastasis, via spatial proteomics (IMC) of a patient biopsy. Overlaid with signaling arcs. No genAI was used in its creation.

Together with a lot of preclinical data on the effects of boosting checkpoint inhibition with HDACi, this led us to discovery that the combination therapy acts via activating B cells and breaking physical myeloid suppressive — CD8+ T cell interactions.

This was a big team effort driven by Edgar Gonzalez and Jesse Kreger, and expertly led by the inimitable Evanthia Roussos Torres. …but this is only the beginning. We have so many more questions to tackle next, which this study raised. From fundamental intrinsic/extrinsic control of cancer cell state plasticity to why treatment fails for some patients and at some metastatic sites. Onwards.”

Adam MacLean: A Closer Look at Immune Cell Interactions in Breast Cancer Metastasis

You can also read: Rituximab and Checkpoint Inhibitors: A New Strategy to Prevent Immune-Related Toxicity

Adam MacLean: A Closer Look at Immune Cell Interactions in Breast Cancer Metastasis